PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $347,416 | -5.7% | 68,795 | -6.0% | 0.00% | 0.0% |
Q2 2023 | $368,297 | -56.9% | 73,220 | -47.3% | 0.00% | -50.0% |
Q1 2023 | $854,899 | +81.8% | 139,008 | +290.1% | 0.00% | +100.0% |
Q4 2022 | $470,342 | +473.6% | 35,632 | +29.1% | 0.00% | – |
Q3 2022 | $82,000 | -70.8% | 27,598 | -64.0% | 0.00% | -100.0% |
Q2 2022 | $281,000 | -73.4% | 76,745 | -55.0% | 0.00% | -50.0% |
Q1 2022 | $1,056,000 | +89.6% | 170,479 | +147.3% | 0.00% | +100.0% |
Q4 2021 | $557,000 | -35.8% | 68,929 | +18.5% | 0.00% | -75.0% |
Q3 2021 | $867,000 | +331.3% | 58,173 | +31.5% | 0.00% | +300.0% |
Q1 2021 | $201,000 | – | 44,232 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |